Parkinson Disease Psychosis

• FDA label_change · 2023-09-15
  FDA Approved: NUPLAZID — Supplemental Application (Acadia Pharmaceuticals Inc.)

  FDA approved Acadia's supplemental application for NUPLAZID (pimavanserin tartrate), resulting in an updated labeling for the product. The c…

• FDA label_change · 2020-11-23
  FDA Approved: NUPLAZID — Supplemental Application (Acadia Pharmaceuticals Inc.)

  FDA approved a supplemental application for Nuplazid (pimavanserin tartrate) from Acadia Pharmaceuticals, resulting in updated labeling.

• FDA label_change · 2019-09-27
  FDA Approved: NUPLAZID — Supplemental Application (Acadia Pharmaceuticals Inc.)

  The FDA approved a supplemental application for NUPLAZID (pimavanserin tartrate) submitted by Acadia Pharmaceuticals, resulting in updated l…

• FDA label_change · 2018-06-28
  FDA Approved: NUPLAZID — Supplemental Application (Acadia Pharmaceuticals Inc.)

  FDA is reviewing a supplemental application for Nuplazid (pimavanserin tartrate) from Acadia Pharmaceuticals, seeking labeling changes.